Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Cumberland Pharmaceuticals Inc changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 20 | 33 | +13 |
| Shares | 1.84M | 4.28M | +2.44M (+132.4%) |
| Value | $4.36M | $18.1M | +$13.8M (+315.9%) |
New holders (14)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 809,897 | $3.43M | 0.00% |
| Ikarian Capital, LLC | 740,000 | $3.13M | 1.02% |
| J. Goldman & Co LP | 241,481 | $1.02M | 0.04% |
| Boothbay Fund Management, LLC | 223,798 | $946.7K | 0.03% |
| Berkshire Asset Management LLC | 153,810 | $692.1K | 0.03% |
| Adage Capital Partners GP, L.L.C. | 150,000 | $634.5K | 0.00% |
| EAM Investors, LLC | 71,776 | $303.6K | 0.05% |
| Walleye Capital LLC | 70,419 | $297.9K | 0.00% |
| Susquehanna International Group, LLP | 28,939 | $122.4K | 0.00% |
| Citadel Advisors LLC | 25,814 | $109.2K | 0.00% |
| Simplex Trading, LLC | 19,100 | $80.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 17,900 | $75.7K | 0.00% |
| Wiley Bros.-Aintree Capital, LLC | 11,000 | $48.5K | 0.00% |
| Centiva Capital, LP | 1,600 | $6.77K | 0.00% |
Sold out (1)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 2,218 | $5.26K |